BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10601978)

  • 1. Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
    Coutts AS; Leygue E; Murphy LC
    J Mol Endocrinol; 1999 Dec; 23(3):325-36. PubMed ID: 10601978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of estrogen receptor variants in prostate cancer cell lines.
    Ye Q; Chung LW; Cinar B; Li S; Zhau HE
    J Steroid Biochem Mol Biol; 2000 Dec; 75(1):21-31. PubMed ID: 11179905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
    Horvath G; Leser G; Helou K; Henriksson M
    Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas.
    Jacobs HM; van Spriel AB; Koehorst SG; Thijssen JH; Blaauw G; Blankenstein MA
    J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):167-72. PubMed ID: 10704905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
    Chan CM; Dowsett M
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of an estrogen receptor messenger RNA containing exon 1' sequences in MCF-7 breast cancer cell line stocks.
    Sullivan JA; Spriggs LL; Hill SM
    Cancer Lett; 2000 Jan; 148(1):87-93. PubMed ID: 10680597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
    Poola I; Speirs V
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.
    Castles CG; Klotz DM; Fuqua SA; Hill SM
    Br J Cancer; 1995 May; 71(5):974-80. PubMed ID: 7734323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
    Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
    Zhao H; Hart LL; Keller U; Holth LT; Davie JR
    J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of estrogen receptor-alpha gene expression by epidermal growth factor.
    Stoica A; Saceda M; Doraiswamy VL; Coleman C; Martin MB
    J Endocrinol; 2000 May; 165(2):371-8. PubMed ID: 10810301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction.
    Daffada AA; Johnston SR; Nicholls J; Dowsett M
    J Mol Endocrinol; 1994 Dec; 13(3):265-73. PubMed ID: 7893344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Apr; 162(1-2):167-80. PubMed ID: 10854710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.